CA Stock MarketDetailed Quotes
CYTO Cytophage Technologies Ltd
- 0.280
- -0.025-8.20%
15min DelayMarket Closed Sep 13 16:00 ET
15.06MMarket Cap-4745P/E (TTM)
0.305High0.280Low15.00KVolume0.305Open0.305Pre Close4.33KTurnover0.76052wk High0.03%Turnover Ratio53.80MShares0.28052wk Low-0.059EPS TTM13.18MFloat Cap0.760Historical High0.00P/E (Static)47.06MShs Float0.280Historical Low--EPS LYR8.20%Amplitude--Dividend TTM2.86P/B1Lot Size--Div YieldTTM
Cytophage Technologies Ltd Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -114.94%-1.04M | -121.37%-2.11M | -320.09%-195.23K | 5.12%2.07M | -828.25K | -483.21K | -952.12K | 98.47%-46.47K | 1.97M | -3.03M |
| Net income from continuing operations | -7.66%-1.25M | -268.99%-4.28M | 103.12%22.01K | 58.10%3.36M | ---1.02M | ---1.16M | ---1.16M | 78.17%-706.21K | --2.13M | ---3.24M |
| Depreciation and amortization | 55.97%173.21K | 63.86%178.16K | ---- | ---- | --113.74K | --111.05K | --108.72K | ---- | ---- | --295.81K |
| Remuneration paid in stock | ---- | ---- | --0 | -341.53%-523.59K | --48.04K | ---- | ---- | 1,151.12%666.3K | --216.78K | --53.26K |
| Other non cashItems | --25.89K | 107,686.59%2.72M | ---- | ---- | ---- | ---- | --2.52K | 6,530.70%66.31K | ---- | --1K |
| Change In working capital | -90.01%9.07K | -836.65%-719.21K | -198.11%-217.23K | -152.93%-438.61K | --32.94K | --90.81K | --97.63K | 50.43%-72.87K | ---173.41K | ---146.99K |
| -Change in receivables | 156.68%14.12K | -120.95%-51.86K | -181.77%-241.42K | -275.76%-447.65K | ---16.45K | ---24.92K | --247.59K | -235.03%-85.68K | ---119.13K | ---25.57K |
| -Change in prepaid assets | 2,351.82%143.85K | -269.40%-205.96K | -104.64%-965 | 120.13%68.97K | ---7.79K | ---6.39K | ---55.76K | 309.32%20.78K | --31.33K | ---9.93K |
| -Change in payables and accrued expense | -221.94%-148.9K | -389.77%-461.39K | 415.50%25.15K | 29.99%-59.93K | --57.18K | --122.11K | ---94.21K | 92.85%-7.97K | ---85.61K | ---111.49K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -114.95%-1.04M | -121.37%-2.11M | -320.09%-195.23K | 5.12%2.07M | ---828.25K | ---483.21K | ---952.12K | 98.47%-46.47K | --1.97M | ---3.03M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -1,039.42%-778.85K | 37,250.01%7.79M | 102.92%131.03K | 106.21%256.27K | -35.92K | -68.36K | -20.96K | -1,245.85%-4.48M | -4.13M | -333.08K |
| Net PPE purchase and sale | -1,039.42%-778.85K | -197.02%-62.25K | ---- | ---- | ---35.92K | ---68.36K | ---20.96K | ---- | ---- | ---333.08K |
| Net business purchase and sale | --0 | --5.39M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
| Net investment purchase and sale | ---- | ---- | 98.73%-57.55K | ---- | ---- | ---- | ---- | ---4.53M | ---- | ---- |
| Interest received (cash flow from investment activities) | ---- | ---- | 404.97%213.58K | ---- | ---- | ---- | ---- | --42.3K | ---- | ---- |
| Net other investing changes | --0 | --2.46M | ---25K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -1,039.42%-778.85K | 37,250.01%7.79M | 102.92%131.03K | 106.21%256.27K | ---35.92K | ---68.36K | ---20.96K | -1,245.85%-4.48M | ---4.13M | ---333.08K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -128.18%-95.62K | -241.66%-142.37K | 0 | -113.61%-615.45K | 175.67K | 339.28K | 100.5K | -33.00%4.41M | 4.52M | 6.58M |
| Net issuance payments of debt | -164.64%-100.62K | -170.53%-113.62K | ---- | ---- | ---40.34K | ---38.02K | ---42K | ---- | ---- | ---130.62K |
| Net common stock issuance | --0 | 1,654.39%2.5M | --0 | -110.45%-522.69K | --216K | --164.19K | --142.5K | -24.14%5M | --5M | --6.59M |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --215.05K |
| Net other financing activities | --0 | ---2.53M | ---- | ---- | --0 | ---- | ---- | -544.43%-588.43K | ---- | ---91.31K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -128.18%-95.62K | -241.66%-142.37K | --0 | -113.61%-615.45K | --175.67K | --339.28K | --100.5K | -33.00%4.41M | --4.52M | --6.58M |
| Net cash flow | ||||||||||
| Beginning cash position | 305.27%5.57M | -98.59%31.68K | -62.86%69.5K | -79.99%472.97K | --1.16M | --1.37M | --2.25M | -88.47%187.11K | --2.36M | --1.62M |
| Current changes in cash | -800.79%-1.91M | 734.53%5.54M | 45.42%-64.19K | -27.60%1.71M | ---688.51K | ---212.38K | ---872.48K | -103.65%-117.61K | --2.36M | --3.22M |
| End cash Position | 214.66%3.65M | 305.27%5.57M | -92.36%5.31K | -92.36%5.31K | --472.97K | --1.16M | --1.37M | -98.56%69.5K | --69.5K | --4.84M |
| Free cash from | -229.52%-1.82M | -123.00%-2.17M | -320.09%-195.23K | -5.55%2.19M | ---864.17K | ---551.56K | ---973.08K | 98.62%-46.47K | --2.32M | ---3.37M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data